Abstract
Case studies conducted after recovery from acute infection with SARS-CoV-2 have frequently identified abnormalities on CMR imaging, suggesting the possibility that SARS-CoV-2 infection commonly leads to cardiac pathology. However, these observations have not been able to distinguish between associations that reflect pre-existing cardiac abnormalities (that might confer a greater likelihood of more severe infection) from those that arise as consequences of infection. To address this question, UK Biobank volunteers (n=1285; 54.5% women; mean age at baseline, 59.8 years old; 96.3% white) who attended an imaging assessment including cardiac magnetic resonance (CMR) before the start of the COVID-19 pandemic were invited to attend a second imaging assessment in 2021. Cases with evidence of previous SARS-CoV-2 infection were identified through linkage to PCR-testing or other medical records, or a positive antibody lateral flow test; n=640 in data available on 22 Sep 2021) and were matched to controls with no evidence of previous infection (n=645). The majority of these infections were milder and did not involve hospitalisation. Measures of cardiac and aortic structure and function were derived from the CMR images obtained on the cases before and after SARS-CoV-2 infection from images for the controls obtained over the same time interval using a previously validated, automated algorithm. Cases and controls had similar cardiac and aortic imaging phenotypes at their first imaging assessment. Changes between CMR imaging measures in cases before and after infection were not significantly different from those in the matched control group. Additional adjustment for comorbidities made no material difference to the results. While these results are preliminary and limited to imaging metrics derived from automated analyses, they do not suggest clinically significant persistent cardiac pathology in the UK Biobank population after generally milder (non-hospitalised) SARS-CoV-2 infection.
Introduction
Early cross-sectional studies during the COVID-19 pandemic suggested high rates of cardiac abnormalities, such as myocarditis or reduced ejection fraction, in post-recovery patients. However, these findings were often confounded by reverse causation bias: without pre-infection data, it was impossible to determine if the virus caused the damage or if individuals with pre-existing cardiac issues were more susceptible to infection. This study leverages the unique longitudinal data of the UK Biobank to compare cardiac health before and after infection, providing a definitive baseline for assessment.
Methods and Study Population
This nested case-control study utilized the UK Biobank Imaging Enhancement Study, which provided Cardiac Magnetic Resonance (CMR) scans for participants both before the pandemic (2014–2020) and again in 2021.
The study population consisted of:
- Cases (n=640): Individuals with a pre-pandemic scan who subsequently tested positive for SARS-CoV-2.
- Controls (n=645): A group matched for age, sex, and ethnicity who remained COVID-negative between their two scans.
To ensure objective analysis, the researchers employed a validated, automated image analysis pipeline powered by convolutional neural networks (CNNs). This pipeline extracted 27 distinct imaging phenotypes, including chamber volumes, ejection fractions, myocardial strain, and aortic distensibility.
Results
Baseline Similarity
At the first imaging assessment (pre-pandemic), the case and control groups exhibited nearly identical cardiac and aortic imaging phenotypes. This baseline similarity confirms the effectiveness of the matching process and provides a stable foundation for longitudinal comparison.
Longitudinal Stability
The primary analysis revealed that the changes in CMR imaging measures over the 3.2-year average interval were not significantly different between the COVID-19 cases and the control group. Even after adjusting for comorbidities, no statistically significant persistent pathology was detected in the cases.
While a small subgroup of hospitalized patients (n=30) showed a minor increase in Right Atrial (RA) stroke volume, the vast majority of metrics remained stable across the entire cohort. Given that 95.3% of the cases were non-hospitalized, these results are highly representative of the general population's experience with mild SARS-CoV-2 infection.
Discussion and Conclusion
These findings suggest that for the majority of individuals who experience mild SARS-CoV-2 infection, there is no evidence of clinically significant, persistent structural or functional cardiac damage. The abnormalities reported in earlier cross-sectional studies likely reflected pre-existing conditions rather than new, virus-induced pathology.
Limitations
While robust, this study has limitations. The cohort predominantly experienced mild infections, meaning the results may not apply to "Long COVID" patients with severe symptoms or those who suffered extreme multi-organ failure. Additionally, while automated CNN pipelines are highly effective for structural metrics, they may miss subtle tissue-level changes like focal scarring that might be detected through manual expert review or advanced T1/T2 mapping techniques. Future research incorporating radiomics and ECG data may further refine our understanding of post-viral cardiac health.
Summary updated